Welcome to the 6th Microbiome Movement - Drug Development Summit

The most comprehensive forum for microbiome drug developers, the Microbiome Movement – Drug Development Summit returns for its sixth iteration!

We will continue to unite forward thinking researchers from the biopharmaceutical and academic communities to pursue the causal role of the microbiome in disease, making this the must attend conference for those translating microbiome science into clinically successful therapeutics.

Although there has been recent late-stage clinical success, there still remains a number of challenges that need to be overcome in order for the potential of this complex science area to be realized. From understanding microbiome functionality, leveraging lessons from clinical development and scaling manufacturing processes, through to utilizing microbiome biomarkers for patient stratification and diagnostics, our discussion will cover the latest scientific findings and industry updates from the end-to-end development of microbiome therapeutics.

The 6th Microbiome Movement – Drug Development Summit will provide the perfect opportunity for a collaborative approach to develop a new generation of microbiome-targeted therapeutics that improves patients lives.

Our 65+ World Class Speakers Include

Gokul Swaminathan

Associate Principal Scientist, Investigational Biology

Merck Exploratory Science

Ken Blount

Ken Blount



Matthew Henn

Executive VP & CSO

Seres Therapeutics

Stephanie Culler

Co-Founder & CEO

Persephone Biosciences

Fyza Shaikh


John Hopkins Medical Center

Mark Smith

Mark Smith


Finch Therapeutics

Nancy Caralla

Founding President & Executive Director

C.diff Foundation

Paul Carlson

Principal Investigator


Hear What the Microbiome Community Says

"The Microbiome Movement – Drug Development Summit is the premier meeting in the microbiome field, and a “must-attend” for those involved in microbiome related drug development”

Blake Wise, Novome Biotechnologies

"This summit offers great opportunity for researchers to share findings and advancements in the microbiome field, and greatly fosters the development of microbiome-based therapeutics and diagnostis

Xue Liang, Merck Exploratory Science

Confirmed Partners for 2021 Include

Lead Partner:

Boston Analytical

Expertise Partners:

ArrantaBio_Logo_CMYK (002)

Other Confirmed Partners:

logo 1500x1500px v2
Loop Genomics - Partner
Vaiomer - 2021 Partner
polardry_logo_wtag 110419
Human Metabolome Technologies - Innovation Partner

Other Events In The Series